M, S., JL, P., & J, A. (2021). Rationale for Use of an FDA-Cleared Delivery System for Administration of Inhaled Nitric Oxide in Patients Undergoing Magnetic Resonance Imaging. Dove Medical Press.
Style de citation Chicago (17e éd.)M, Salas, Potenziano JL, et Acker J. Rationale for Use of an FDA-Cleared Delivery System for Administration of Inhaled Nitric Oxide in Patients Undergoing Magnetic Resonance Imaging. Dove Medical Press, 2021.
Style de citation MLA (8e éd.)M, Salas, et al. Rationale for Use of an FDA-Cleared Delivery System for Administration of Inhaled Nitric Oxide in Patients Undergoing Magnetic Resonance Imaging. Dove Medical Press, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.